Suture versus open mesh repair for small umbilical hernia: Results of a propensity-matched cohort study.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
09 2023
Historique:
received: 04 11 2022
revised: 14 04 2023
accepted: 24 05 2023
medline: 8 8 2023
pubmed: 26 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

The objective was to compare the outcomes of open mesh repair versus suture repair for small (≤1 cm in diameter) umbilical hernia. The primary endpoint was the 30-day outcomes including pain, and secondary endpoints were the 2-year outcomes including recurrences and patient-reported outcomes. This propensity-matched, multicenter study was carried out on data collected prospectively in the Hernia-Club database between 2011 and 2021. A total of 590 mesh repairs and 590 suture repairs were propensity score matched (age, sex, body mass index) at a ratio of 1:1. Postoperative pain was assessed using the Verbal Rating Scale-4 and 0‒10 Numerical Rating Scale-11. Mesh insertion was intraperitoneal in 331 patients (56.1%), extraperitoneal in 249 (42.2%), and onlay in 10 (1.7%). The rate of 30-day complications and Numerical Rating Scale-11 pain scores on postoperative days 8 and 30 were similar between the groups, including surgical site occurrences (2.2 vs 1.4% after suture repair). At 1 month, postoperative discomfort (sensation of something different from before) was significantly (P < .0001) more frequent after mesh repair, whereas the rate of relevant (moderate or severe) pain (mesh repair: 1.1% vs suture repair: 2.6%) and the distribution of Numerical Rating Scale-11 scores did not differ between the groups. At the 2-year follow-up, mesh repair patients had fewer reoperated recurrences (0.2% vs 1.7%; P = .035) and no more pain or discomfort than suture repair patients. Both techniques are effective and safe. Mesh repair is likely to reduce the rate of recurrences. Concerns about postoperative pain and infection might not prevent the use of mesh in smallest umbilical hernias.

Sections du résumé

BACKGROUND
The objective was to compare the outcomes of open mesh repair versus suture repair for small (≤1 cm in diameter) umbilical hernia. The primary endpoint was the 30-day outcomes including pain, and secondary endpoints were the 2-year outcomes including recurrences and patient-reported outcomes.
METHODS
This propensity-matched, multicenter study was carried out on data collected prospectively in the Hernia-Club database between 2011 and 2021. A total of 590 mesh repairs and 590 suture repairs were propensity score matched (age, sex, body mass index) at a ratio of 1:1. Postoperative pain was assessed using the Verbal Rating Scale-4 and 0‒10 Numerical Rating Scale-11.
RESULTS
Mesh insertion was intraperitoneal in 331 patients (56.1%), extraperitoneal in 249 (42.2%), and onlay in 10 (1.7%). The rate of 30-day complications and Numerical Rating Scale-11 pain scores on postoperative days 8 and 30 were similar between the groups, including surgical site occurrences (2.2 vs 1.4% after suture repair). At 1 month, postoperative discomfort (sensation of something different from before) was significantly (P < .0001) more frequent after mesh repair, whereas the rate of relevant (moderate or severe) pain (mesh repair: 1.1% vs suture repair: 2.6%) and the distribution of Numerical Rating Scale-11 scores did not differ between the groups. At the 2-year follow-up, mesh repair patients had fewer reoperated recurrences (0.2% vs 1.7%; P = .035) and no more pain or discomfort than suture repair patients.
CONCLUSION
Both techniques are effective and safe. Mesh repair is likely to reduce the rate of recurrences. Concerns about postoperative pain and infection might not prevent the use of mesh in smallest umbilical hernias.

Identifiants

pubmed: 37357098
pii: S0039-6060(23)00310-0
doi: 10.1016/j.surg.2023.05.015
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

593-601

Investigateurs

M Antor (M)
M Beck (M)
C Barrat (C)
C Berney (C)
D Binot (D)
J Bousquet (J)
D Blazquez (D)
A Bonan (A)
O Cas (O)
A Champault-Fezais (A)
P Chastan (P)
J-M Chollet (JM)
J-P Cossa (JP)
A Dabrowski (A)
T Delaunay (T)
S Démaret (S)
F Drissi (F)
H Demian (H)
V Dubuisson (V)
T Dugue (T)
G Fromont (G)
J-F Gillion (JF)
C Jacquin (C)
F Jurczak (F)
H Khalil (H)
M Launay-Savary (M)
M Lepère (M)
D Lépront (D)
J H Longeville (JH)
N Le Toux (N)
J Loriau (J)
E Magne (E)
P Ngo (P)
O Oberlin (O)
G Passot (G)
X Pavis d'Escurac (X)
J B Putinier (JB)
Y Renard (Y)
B Romain (B)
M Soler (M)
S Roos (S)
J-M Thillois (JM)
P Tiry (P)
P Vu (P)
R Verhaeghe (R)
M Warlaumont (M)
C Zaranis (C)

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Samuel Frey (S)

Nantes Université, CHU Nantes, Chirurgie Cancérologique, Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif, Nantes, France. Electronic address: samuel.frey@chu-nantes.fr.

Adrien Beauvais (A)

HORIANA, Bordeaux, France.

Marc Soler (M)

Service de chirurgie viscérale et digestive, Clinique Saint-Jean, Cagnes-sur-Mer, France.

Mathieu Beck (M)

Clinique Ambroise Paré, Thionville, France.

Timothée Dugué (T)

Service de chirurgie viscérale et digestive, Clinique Saint Pierre, Perpignan, France.

Xavier Pavis d'Escurac (X)

Clinique Rhena, Strasbourg, France.

André Dabrowski (A)

Service de chirurgie viscérale et digestive, Clinique de Saint-Omer, Blendecques, France.

Florent Jurczak (F)

Service de chirurgie digestive et viscérale, Clinique Mutualiste de l'Estuaire, Saint-Nazaire, France.

Jean-François Gillion (JF)

Ramsay Santé Hôpital Privé d'Antony, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH